Fady Malik, Executive VP at Cytokinetics Inc, sold 7,788 shares on June 11, 2024, bringing his total to 135,004 shares. The company focuses on developing muscle function modulating therapeutics.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing